---
title: "Newborn Bloodspot Cards"
ocid: "ocds-r6ebe6-0000806214"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000806214"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000806214.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000806214.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "NHS GREATER GLASGOW AND CLYDE"
published: "2025-09-05"
---

# Newborn Bloodspot Cards

Buyer: NHS GREATER GLASGOW AND CLYDE  
Current stage: Award  
OCID: ocds-r6ebe6-0000806214

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000806214)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000806214.json)

## Summary

NHS Greater Glasgow and Clyde has recently concluded a procurement process for the acquisition of Newborn Bloodspot Cards, aimed at supporting the Scottish newborn screening programme. This contract falls under the health industry category and involves the supply of 80,000 bespoke bloodspot cards, which are essential for newborn screening across the UK. The procurement was conducted under a limited method, without prior publication of a competitive call, due to the specific technical requirements mandated by the UK National Screening Committee. Located in Glasgow, the contracting authority finalised the contract with Revvity (UK) Ltd., the sole licensed supplier, on the 1st of August 2025 for a value of £158,772.

This contract presents substantial business opportunities, particularly for suppliers specialising in medical device manufacturing and public health services. The demand for bespoke and highly regulated screening tools aligns business growth with public health objectives, offering avenues for future innovations in diagnostic tools. Companies that can leverage technology and expertise in bespoke manufacturing or have alignment with public health directives would be well-positioned to collaborate with public health bodies like NHS Greater Glasgow and Clyde in similar tenders. Although this contract has been awarded, understanding these key requirements and regulatory constraints can inform strategic planning and proposal development for similar opportunities within the health sector.

## Notice

NHS Greater Glasgow and Clyde require Scottish new born screening blood spot cards with envelopes.

### Lot Information

Lot 1

NHS Greater Glasgow and Clyde (NHSGGC) hosts the nationally commissioned Scottish New born Screening Laboratory (herein 'SNSL') which provides the new born blood spot screening for all babies born in Scotland. The SNSL provides all fourteen regional health boards in Scotland with the dried blood spot card, this is a CE, IVD marked sample collection device (herein 'the bloodspot card'). The local midwifery services use the bloodspot cards to take a heel prick sample from all new born babies, these samples are then returned to the SNSL where sample processing takes place. The bloodspot programmes bespoke screening cards are specifically designed by the National Services Division for the purpose of screening new born babies in Scotland for a number of diseases. The design of the cards includes a card portion which can be completed by the midwife to include all required demographical information for the baby, and a filter paper portion where the blood is applied. The filter paper must adhere to the standards detailed by the CLSI. The specifications for the screening card are extremely complex and well-regulated to ensure the screening programme can be sensitive, specific and safe for patients. Alternative blood collection devices, including different types of filter paper cannot be used as they will not meet the specifications for the Scottish screening programme. NHS Greater Glasgow and Clyde require supply of an annual order of the Scottish new born screening blood spot cards and glassine envelopes. The bloodspot cards are a specific type that is mandated by legislation from the UK National Screening Committee. NHS Greater Glasgow and Clyde will purchase 80,000 cards with envelopes printed using Ahlstrom 226 filter paper in one batch.

### Procurement Information

Newborn bloodspot screening in the UK is a public health initiative which requires equity across all devolved nations. As such screening in Scotland is overseen by the National Screening Committee, which is part of UK government. Alignment of the screening programme is essential to allow consistent and transferable screening of all newborn babies in the UK. With this in mind, although many of the processes used for UK newborn screening are not mandated, they are governed by the UK Newborn Screening Laboratory Network, to ensure that accurate screening is taking place. One of the essential elements to this is to ensure that all screening algorithms, including the analytical cut of values are the same across all four nations. To allow this to happen it is essential that the techniques used for screening are the same. This includes ensuring that all nations employ the same sample requirements. This means that the devise with which we use to take newborn blood spot samples must be the same across all nations and must be the same as the one used to validate the screening processes. In the UK, all nations must use the same type of filter paper in the sample collection devise. Since the collection of newborn blood spot samples began in the 1960s, this has been the specific brand of filter paper Ahlstrom 226. The only licence to use the Ahlstrom 226 filter paper is held by Revvity, therefore the purchase of newborn bloodspot cards in the UK can only come from Revvity. Revvity purchase the filter paper as a roll from Ahlstrom and use it to create the bespoke bloodspot card design that we use in Scotland. The filter paper comes with a Certificate of Analysis and a report from the Centre for Disease Control, and both of these ensure the paper is consistent with the newborn screening requirements CLSI NBS-01 Ed7. There are no other commercial companies that can purchase and use Ahlstrom 226 filter paper to make newborn screening samples. It is important to note that whist other brands of filter paper are available for purchase, this would mean that all screening algorithms in use would have to be re-validated and would mean that Scotland deviates from the UK wide national protocols. This would be extremely costly, time consuming and is not recommended by the Scottish Screening Committee. For this reason, the only supplier of bloodspot screening cards in Scotland is Revvity.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP538574 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 5 Sep 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 1 Aug 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £158,772 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS GREATER GLASGOW AND CLYDE |
| Locality | GLASGOW |
| Post town | Glasgow |
| Postcode | G4 0SF |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM3 West Central Scotland |
| ITL 3 | TLM32 Glasgow City |
| Local authority | Glasgow City |
| Electoral ward | Dennistoun |
| Westminster constituency | Glasgow North East |
| Delivery location | TLM82 Glasgow City |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | REVVITY (UK |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33140000 - Medical consumables

## Release History

- 5 Sep 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP538574
- 5 Aug 2025 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536263

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536263
  Newborn Bloodspot Cards - NHS Greater Glasgow and Clyde require Scottish new born screening blood spot cards with envelopes.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP538574
  Newborn Bloodspot Cards - NHS Greater Glasgow and Clyde require Scottish new born screening blood spot cards with envelopes.

## Notice URLs

- http://
- http://www.nhsggc.scot/about-us/procurement/
- http://www.scotcourts.gov.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000806214

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000806214. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000806214.json.